← The Wire
CGONNasdaq
CG Oncology, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1991792
Develops and commercializes cretostimogene grenadenorepvec, an immunotherapy for bladder cancer
red 8-K · 90d
$5.25B
Market cap
$73.73
Last close
+2.5%
1D
+11.3%
5D
1.1M
Volume
Price · last 39 sessions+8.9%
May 4L $53.72 · H $74.00Jun 29
58
Total filings
Jun 8, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 8, 202610-Q10-QNov 14, 202510-Q10-QAug 8, 202510-Q10-QMay 13, 202510-Q10-QNov 12, 202410-Q10-QAug 8, 202410-Q10-QMay 9, 2024
Insider Activity
In the 90 days to Mar 16, 2026: 1 sold $710K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Mulay JamesDirector | Sell | 1,310 | $63.50 | $83K |
| Mar 16, 2026 | Mulay JamesDirector | Sell | 654 | $63.50 | $42K |
| Jan 9, 2026 | Mulay JamesDirector | Sell | 10,491 | $52.99 | $556K |
| Jan 9, 2026 | Mulay JamesDirector | Sell | 654 | $44.16 | $29K |
| Nov 17, 2025 | Post Leonard EDirector | Sell | 1,000 | $41.43 | $41K |
| Oct 13, 2025 | Post Leonard EDirector | Sell | 1,000 | $43.25 | $43K |
| Oct 9, 2025 | Mulay JamesDirector | Sell | 5,903 | $43.99 | $260K |
| Sep 30, 2025 | Post Leonard EDirector | Sell | 5,000 | $40.09 | $200K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance